Literature DB >> 30703284

Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Weiyi Mu1, Michael Muriello1, Julia L Clemens1, You Wang2, Christy H Smith1, Phuong T Tran3,4, Peter C Rowe1, Clair A Francomano5, Antonie D Kline5, Joann Bodurtha1.   

Abstract

Hypermobile Ehlers-Danlos syndrome (hEDS) is a hereditary disorder of connective tissue, often presenting with complex symptoms can include chronic pain, fatigue, and dysautonomia. Factors influencing functional disability in the pediatric hEDS population are incompletely studied. This study's aims were to assess factors that affect quality of life in children and adolescents with hEDS. Individuals with hEDS between the ages 12-20 years and matched parents were recruited through retrospective chart review at two genetics clinics. Participants completed a questionnaire that included the Pediatric Quality of Life Inventory (PedsQL™), PedsQL Multidimentional Fatigue Scale, Functional Disability Inventory, Pain-Frequency-Severity-Duration Scale, the Brief Illness Perception Questionnaire, measures of anxiety and depression, and helpful interventions. Survey responses were completed for 47 children and adolescents with hEDS/hypermobility spectrum disorder (81% female, mean age 16 years), some by the affected individual, some by their parent, and some by both. Clinical data derived from chart review were compared statistically to survey responses. All outcomes correlated moderately to strongly with each other. Using multiple regression, general fatigue and pain scores were the best predictors of the PedsQL total score. Additionally, presence of any psychiatric diagnosis was correlated with a lower PedsQL score. Current management guidelines recommend early intervention to prevent disability from deconditioning; these results may help identify target interventions in this vulnerable population.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescents; children; health-related quality of life; hypermobile Ehlers-Danlos syndrome; pediatric

Mesh:

Year:  2019        PMID: 30703284      PMCID: PMC7029373          DOI: 10.1002/ajmg.a.61055

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  50 in total

1.  Abbreviated instrument to measure hope: development and psychometric evaluation.

Authors:  K Herth
Journal:  J Adv Nurs       Date:  1992-10       Impact factor: 3.187

Review 2.  The role of illness perceptions in patients with medical conditions.

Authors:  Keith J Petrie; Lana A Jago; Daniel A Devcich
Journal:  Curr Opin Psychiatry       Date:  2007-03       Impact factor: 4.741

3.  Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Authors:  Nicoletta Zoppi; Nicola Chiarelli; Silvia Binetti; Marco Ritelli; Marina Colombi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-01-05       Impact factor: 5.187

Review 4.  Gastrointestinal involvement in the Ehlers-Danlos syndromes.

Authors:  Asma Fikree; Gisela Chelimsky; Heidi Collins; Katcha Kovacic; Qasim Aziz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-02-10       Impact factor: 3.908

5.  Musculoskeletal Conditions in a Pediatric Population with Ehlers-Danlos Syndrome.

Authors:  Courtney M Stern; Michael J Pepin; Joan M Stoler; Dennis E Kramer; Samantha A Spencer; Cynthia J Stein
Journal:  J Pediatr       Date:  2016-11-28       Impact factor: 4.406

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

7.  The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome).

Authors:  Brad T Tinkle; Howard A Bird; Rodney Grahame; Mark Lavallee; Howard P Levy; David Sillence
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

Review 8.  Hypermobility disorders in children and adolescents.

Authors:  Kevin J Murray
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-04       Impact factor: 4.098

9.  Psychosocial perspectives in the treatment of pediatric chronic pain.

Authors:  Bryan D Carter; Brooke M Threlkeld
Journal:  Pediatr Rheumatol Online J       Date:  2012-06-07       Impact factor: 3.054

10.  The pain frequency-severity-duration scale as a measure of pain: preliminary validation in a pediatric chronic pain sample.

Authors:  Katherine S Salamon; W Hobart Davies; Melissa R Fuentes; Steven J Weisman; Keri R Hainsworth
Journal:  Pain Res Treat       Date:  2014-01-20
View more
  8 in total

1.  Use of Cluster Analysis to Delineate Symptom Profiles in an Ehlers-Danlos Syndrome Patient Population.

Authors:  Jane R Schubart; Eric Schaefer; Alan J Hakim; Clair A Francomano; Rebecca Bascom
Journal:  J Pain Symptom Manage       Date:  2019-05-31       Impact factor: 3.612

2.  Societal participation in ehlers-danlos syndromes and hypermobility spectrum disorder, compared to fibromyalgia and healthy controls.

Authors:  Stijn De Baets; Ellen Cruyt; Patrick Calders; Inge Dewandele; Fransiska Malfait; Guy Vanderstraeten; Geert Van Hove; Dominique van De Velde
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

3.  Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review.

Authors:  Muhammad Maarj; Andrea Coda; Louise Tofts; Cylie Williams; Derek Santos; Verity Pacey
Journal:  BMC Pediatr       Date:  2021-11-29       Impact factor: 2.125

4.  Heritable connective tissue disorders in childhood: Decreased health-related quality of life and mental health.

Authors:  Jessica Warnink-Kavelaars; Lisanne E de Koning; Lies Rombaut; Leonie A Menke; Mattijs W Alsem; Hedy A van Oers; Annemieke I Buizer; Raoul H H Engelbert; Jaap Oosterlaan
Journal:  Am J Med Genet A       Date:  2022-04-08       Impact factor: 2.578

5.  Quality of Life in Children and Adolescents with Stickler Syndrome in Spain.

Authors:  Juan José Fernández-Pérez; Paloma Mascaraque-Ruiz; Carlos Martín Gómez; Ignacio Martínez-Caballero; Teresa Otón; Loreto Carmona; Sergio Lerma Lara
Journal:  Children (Basel)       Date:  2022-08-19

Review 6.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

7.  Heritable Connective Tissue Disorders in Childhood: Increased Fatigue, Pain, Disability and Decreased General Health.

Authors:  Jessica Warnink-Kavelaars; Lisanne E de Koning; Lies Rombaut; Mattijs W Alsem; Leonie A Menke; Jaap Oosterlaan; Annemieke I Buizer; Raoul H H Engelbert
Journal:  Genes (Basel)       Date:  2021-05-28       Impact factor: 4.096

8.  Psychosocial Influence of Ehlers-Danlos Syndrome in Daily Life of Patients: A Qualitative Study.

Authors:  Inmaculada C Palomo-Toucedo; Fatima Leon-Larios; María Reina-Bueno; María Del Carmen Vázquez-Bautista; Pedro V Munuera-Martínez; Gabriel Domínguez-Maldonado
Journal:  Int J Environ Res Public Health       Date:  2020-09-03       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.